JP2019517540A5 - - Google Patents

Info

Publication number

JP2019517540A5

JP2019517540A5 JP2018563815A JP2018563815A JP2019517540A5 JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5 JP 2018563815 A JP2018563815 A JP 2018563815A JP 2018563815 A JP2018563815 A JP 2018563815A JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5

Authority

JP

Japan

Prior art keywords

subject

composition

antibody

administered

body weight

Prior art date

2017-06-06

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 230000037396 body weight Effects 0.000 claims description 156
• 238000000034 method Methods 0.000 claims description 72
• 206010072599 Amyloid related imaging abnormalities Diseases 0.000 claims description 46
• 208000024891 symptom Diseases 0.000 claims description 32
• 208000024827 Alzheimer disease Diseases 0.000 claims description 22
• 230000001186 cumulative effect Effects 0.000 claims description 15
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
• 108010060159 Apolipoprotein E4 Proteins 0.000 claims description 10
• 208000031856 Haemosiderosis Diseases 0.000 claims description 7
• 230000008034 disappearance Effects 0.000 claims description 6
• 210000004556 brain Anatomy 0.000 claims description 5
• 230000002490 cerebral effect Effects 0.000 claims description 4
• 230000007570 microbleeding Effects 0.000 claims description 4
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 2
• 102100031759 Endothelial cell-specific chemotaxis regulator Human genes 0.000 claims 21
• 101710183128 Endothelial cell-specific chemotaxis regulator Proteins 0.000 claims 21
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 108010017480 Hemosiderin Proteins 0.000 claims 1
• 230000005856 abnormality Effects 0.000 claims 1
• 230000008021 deposition Effects 0.000 claims 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1